SANA

Sana Biotechnology (SANA)

Sana Biotechnology Inc

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:SANA

<< Previous 1 2 3 4 5 6 7 Next >>

Date	Time	Source	Headline	Symbol	Company
03/08/2022	9:07AM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SANA	Sana Biotechnology Inc
03/08/2022	9:04AM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SANA	Sana Biotechnology Inc
03/08/2022	9:03AM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SANA	Sana Biotechnology Inc
02/28/2022	9:00AM	PR Newswire (US)	Alltrna Appoints Rare Disease Clinical Research Expert, Dr. Anne Pariser, as Vice President, Medical and Regulatory Affairs	NASDAQ:SANA	Sana Biotechnology Inc
02/15/2022	10:05AM	PR Newswire (US)	INVAIO SCIENCES STRENGTHENS ITS BOARD OF DIRECTORS WITH THE APPOINTMENT OF HUGH GRANT	NASDAQ:SANA	Sana Biotechnology Inc
02/14/2022	5:35PM	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:SANA	Sana Biotechnology Inc
02/10/2022	5:13PM	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:SANA	Sana Biotechnology Inc
02/09/2022	10:26AM	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:SANA	Sana Biotechnology Inc
01/26/2022	7:04AM	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:SANA	Sana Biotechnology Inc
01/11/2022	6:00AM	GlobeNewswire Inc.	Sana Biotechnology Obtains Exclusive License from National Institutes of Health for CD22 CAR Construct	NASDAQ:SANA	Sana Biotechnology Inc
01/10/2022	4:30PM	GlobeNewswire Inc.	Sana Biotechnology, IASO Biotherapeutics, and Innovent Biologics Announce Non-Exclusive License Agreement for Clinically Validated BCMA CAR Construct	NASDAQ:SANA	Sana Biotechnology Inc
01/04/2022	4:05PM	GlobeNewswire Inc.	Sana Biotechnology to Present at the 40th Annual J.P. Morgan Healthcare Conference	NASDAQ:SANA	Sana Biotechnology Inc
12/17/2021	8:00AM	PR Newswire (US)	Omega Funds Closes Oversubscribed $650 Million Fund VII to Invest in Transformative Life Science Companies	NASDAQ:SANA	Sana Biotechnology Inc
12/17/2021	8:00AM	PR Newswire (US)	Omega Funds Closes Oversubscribed $650 Million Fund VII to Invest in Transformative Life Science Companies	NASDAQ:SANA	Sana Biotechnology Inc
12/12/2021	9:05AM	GlobeNewswire Inc.	Sana Biotechnology Presentations at 2021 ASH Annual Meeting Highlight Progress with Platforms and CAR T Cell Programs	NASDAQ:SANA	Sana Biotechnology Inc
11/08/2021	4:23PM	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:SANA	Sana Biotechnology Inc
11/08/2021	4:05PM	GlobeNewswire Inc.	Sana Biotechnology Reports Third Quarter 2021 Financial Results and Business Updates	NASDAQ:SANA	Sana Biotechnology Inc
11/04/2021	9:07AM	GlobeNewswire Inc.	Sana Biotechnology to Present Pre-Clinical Data at 2021 American Society of Hematology Annual Meeting	NASDAQ:SANA	Sana Biotechnology Inc
10/19/2021	9:11AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SANA	Sana Biotechnology Inc
10/19/2021	9:00AM	GlobeNewswire Inc.	Sana Biotechnology Obtains a Non-Exclusive License to CRISPR Cas12b Gene Editing Technology from Beam Therapeutics to Enable Engineered Cell Programs	NASDAQ:SANA	Sana Biotechnology Inc
10/13/2021	10:11AM	PR Newswire (US)	Invaio Sciences Secures $50 Million Debt Financing to Develop and Commercialize Agricultural Solutions to Address Climate Change	NASDAQ:SANA	Sana Biotechnology Inc
09/21/2021	9:43AM	TipRanks	Looking at Changes in Sana Biotechnology’s Risk Factors	NASDAQ:SANA	Sana Biotechnology Inc
09/13/2021	10:02AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SANA	Sana Biotechnology Inc
09/07/2021	4:05PM	GlobeNewswire Inc.	Sana Biotechnology to Present at the Morgan Stanley 19th Annual Global Healthcare Conference	NASDAQ:SANA	Sana Biotechnology Inc
09/03/2021	4:13PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SANA	Sana Biotechnology Inc
09/03/2021	4:11PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SANA	Sana Biotechnology Inc
09/01/2021	4:21PM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SANA	Sana Biotechnology Inc
08/09/2021	2:00AM	PR Newswire (US)	MaxCyte Signs Clinical and Commercial License with Sana Biotechnology	NASDAQ:SANA	Sana Biotechnology Inc
08/04/2021	4:33PM	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:SANA	Sana Biotechnology Inc
08/04/2021	4:05PM	GlobeNewswire Inc.	Sana Biotechnology Reports Second Quarter 2021 Financial Results and Business Updates	NASDAQ:SANA	Sana Biotechnology Inc